At H2H we offer both Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro/Zepbound)

Semaglutide is the base form of Ozempic/Wegovy and is an injectable medication which helps control blood sugar in type 2 diabetics. Semaglutide belongs to a group of medications called glucagon-like peptide-1 (GLP-1) agonists, which mimic the hormone GLP-1 in your body to lower blood sugar levels after you’ve eaten a meal.

Glucagon-like peptide 1 (GLP-1) is a hormone that has a huge impact on the regulation of blood sugar. It works by stimulating glucose-dependent insulin secretion. Insulin is a hormone that promotes sugar uptake by the cells, stores sugar as glycogen, facilitates the building of fat, and signals the body to build skeletal muscle. Additionally, GLP-1 inhibits glucagon release. This slows down the release of sugar into the blood so that you can burn more fat, slows down gastric emptying (makes you feel full), and drastically reduces the desire for food intake (because you feel full).

Tirzepatide is the base form of Mounjaro/Zepound and is a peptide that has proven its effectiveness for weight loss. It works by mimicking two hormones in the body, GLP-1 and GIP, which regulate blood sugar levels and appetite. Tirzepatide has shown to have a greater percentage of weight loss compared to Semaglutide and less incidence of side effects.

As we age, losing weight can be incredibly difficult. Newly FDA-approved weight-loss medicine is here to help. Studies have demonstrated that Semaglutide and Tirzepatide reduce appetite, improve control of eating, and reduced food cravings in addition to improving glycemic control. The greatest weight loss benefits were observed when used in combination with lifestyle changes.

In 2 months, you could lose up to 25 pounds.

In 4 months, you could lose up to 50 pounds or more!

The goal is in 6 months to lose at least 15% of your body weight.

The program starts you on small dose (0.25mg) once a week for 4 week to minimize the side effects of the medication. We will then slowly increase your dose to a maximum dose of 1mg per week. You must meet (via telemedicine) with our medical doctor once a month for a check in. For maximum results, we will provide a meal plan, and recommend increasing physical activity as well.

Semaglutide and Tirzepatide should not be used if you or your family have a history of certain thyroid cancers such as Medullary thyroid cancer or endocrine neoplasia type 2. They should not be used in people with a history of pancreatitis. GLP-1's should be used cautiously for people on other blood sugar lowering medications.